BioScience Ventures Group AG

Nano4Imaging GmbH, established in 2011 and located in Aachen, Germany, specializes in the development and production of contrast agents and devices designed for in-vivo imaging of medical implants and minimally invasive devices. The company offers a range of products, including MRWire EmeryGlide, a magnetic resonance imaging (MRI) conditional guidewire, and various coatings under the MagnaFy brand that enhance the visibility of devices in different imaging modalities, such as MRI, computed tomography (CT), and X-ray. These innovations facilitate navigation and monitoring during medical interventions, particularly in the treatment of cardiovascular diseases and in radiotherapy. By leveraging advanced nanotechnology, Nano4Imaging aims to improve the accuracy of patient monitoring and intervention outcomes.

MagnaMedics specializes in the engineering and production of magnetic nano- and microparticles utilized in various medical applications, including medical devices, drug delivery tools, and diagnostic kits. The company's products facilitate the determination of biomarkers in body fluids, with a particular emphasis on proteomics. MagnaMedics is dedicated to high-quantity isolation of proteins, which supports research customers who are engaged in high-throughput screening of biomarkers. By providing innovative solutions, MagnaMedics enables manufacturers to conduct in-vitro diagnostics efficiently and effectively.

Apeptico Forschung und Entwicklung GmbH is a biotechnology company based in Vienna, Austria, founded in 2008. The company focuses on the development and commercialization of peptide-based therapeutic drugs aimed at treating chronic and life-threatening diseases. It offers a product portfolio known as PEPBASE, which includes various peptide-based medicinal drugs designed for both therapeutic and prophylactic applications. Through its innovative approach, Apeptico seeks to address significant medical needs in the field of severe and chronic health conditions.

Diaferon is a biotechnology company developing a drug delivery system to control the release and distribution of therapeutic particles.

ugichem is an innovative biotech company based on unique chemistry and focused on the development of novel antisense drugs. Their mission is to turn antisense into therapeutics.